CLC bio wins Venter Institute as bioinformatics customer

By Mass High Tech Staff

UMass team studies human activity via motion sensing [February 27, 2009]

Alnylam to enroll liver cancer patients for Phase 1 study [January 23, 2009]

Mass. life sciences group seeks funding boost from Congress [January 8, 2009]

Sirtris’ Westphal finds new drug discovery role at GSK [January 2, 2009]

Bioinformatics company CLC bio LLC reports it has landed as a customer the J. Craig Venter Institute, the not-for-profit genomic research institute that helped decode the human genome.

The Maryland-based institute has entered into an agreement for a multi-year site license for the whole CLC bio bioinformatics suite of products, implementing CLC bio’s enterprise solution as a scientific platform across all JCVI sites. No financial details of the deal were disclosed.

CLC bio is a Danish company with its North American headquarters in Cambridge. The 41-employee company has offices in Maryland, California, the U.K., India and Brazil.

According to Granger Sutton, senior director of informatics at JCVI, the institute will use CLC bio’s suite across the entire enterprise to integrate, support and enhance workflows across different technology platforms and geographical sites. CLC bio’s product is a gateway that accesses all data and analysis in a single platform, officials say.

JCVI was founded by J. Craig Venter, who is also the founder of sequencing firm Human Genome Sciences Inc. of Maryland.

CLC bio counts among its customers the National Institutes of Health, the University of Rhode Island and Alnylam Pharmaceuticals Inc.

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.